DL-Menthol(b)
CAS No. 1490-04-6
DL-Menthol(b)( —— )
Catalog No. M20400 CAS No. 1490-04-6
DL-Menthol is an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 38 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDL-Menthol(b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDL-Menthol is an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties.
-
DescriptionDL-Menthol is an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
IndicationItchy skin and itchy skin diseases
Chemical Information
-
CAS Number1490-04-6
-
Formula Weight156.26
-
Molecular FormulaC10H20O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1599.80 mM)
-
SMILESCC(C)C1CCC(C)CC1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kozlovich S Chen G Watson CJet al.The role of L- and D-menthol in the glucuronidation and detoxification of the major lung carcinogen NNAL[J].Drug Metab Dispos. 2019 Oct 2. pii: dmd.119.088351
molnova catalog
related products
-
Protosappanin B
Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.
-
Anemarrhenasaponin I
Anemarrhenasaponin I shows the remarkable inhibiting effect on platelet aggregation.
-
(R)-3-Hydroxybutanoi...
3-hydroxybutyric acid is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone) levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis.